Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients.

Saved in:

Bibliographic Details
Title:	Carfilzomib versus rituximab for treatment of de novo donor-specific antibodies in lung transplant recipients.
Authors:	Razia, Deepika^1,2 dr.deepikarazia@gmail.com, Chengcheng Hu³ hucc@arizona.edu, Cherrier, Lauren¹ Lauren.Cherrier@dignityhealth.org, Nasar, Aasya¹ aasya.nasar@commonspirit.org, Walia, Rajat^1,2 rajat.walia@dignityhealth.org, Tokman, Sofya^1,2 sofya.tokman@commonspirit.org
Source:	Transplant Immunology. Dec2022, Vol. 75, p1-7. 7p.
Database:	Academic Search Ultimate

Description
ISSN:	09663274
DOI:	10.1016/j.trim.2022.101703